Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sterling Reese

Interventional Cardiology Sterling, IL Medical Doctor

NPI 1952307886 CMS profile 360422

101 E Miller Rd, Sterling, IL 61081

Open in the dashboard

General payments

$1,641

50 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sterling Reese of Sterling, IL is reported in the CMS Open Payments database as having received $1,641 across 50 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 17th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21 1
2024 General $24 1
2021 General $867 6
2020 General $184 11
2019 General $544 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sterling Reese
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Sterling Reese were reported at $21. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Sterling Reese Interventional Cardiology median Middle half National median
2019 $544 $1,097 $329–$3,048 $163
2020 $184 $473 $161–$1,480 $114
2021 $867 $677 $233–$1,827 $132
2022 $0 $978 $333–$2,724 $149
2023 $0 $1,136 $382–$2,986 $160
2024 $24 $1,181 $395–$3,326 $164
2025 $21 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $896 8 payments
  2. Amgen Inc. $274 13 payments
  3. Novartis Pharmaceuticals Corporation $115 7 payments
  4. Abbott Laboratories $67 3 payments
  5. Pfizer Inc. $50 4 payments
  6. AstraZeneca Pharmaceuticals LP $43 3 payments
  7. Lundbeck LLC $36 2 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $35 2 payments
  9. Acist Medical Systems, Inc. $29 1 payment
  10. E.R. Squibb & Sons, L.L.C. $23 2 payments
  11. Other $73 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $891 49 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $750 1 payment
Products named General payments · program years 2019–2025
  1. LifeVest $896 8 payments
  2. Repatha $274 13 payments
  3. Corlanor $142 7 payments
  4. ENTRESTO $115 7 payments
  5. ELIQUIS $50 4 payments
  6. BRILINTA $43 3 payments
  7. VYNDAQEL $37 3 payments
  8. NORTHERA $36 2 payments
  9. JARDIANCE $35 2 payments
  10. PRADAXA $35 2 payments
  11. Other $193 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$37,602

Medicare's payments for the services billed

Medicare patients

1,067

Average age 74

Services billed

1,682

571 women, 496 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Ischemic heart disease 46%
Diabetes 36%
Chronic kidney disease 31%
Atrial fibrillation 30%
COPD 30%
Heart failure 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

50 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record